Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,229.20
(
1.84%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
95.33
(
-1.71%
)
Bitcoin
75,522.17
(
-0.43%
)
News Focus
News Focus

Replies to post #49690 on Biotech Values

Replies to #49690 on Biotech Values
icon url

microcapfun

07/15/07 6:14 PM

#49693 RE: masterlongevity #49690

Almost every patient on Rituxan progresses. Rituxan sales are ~$2B/year. Should even a therapy which is 2nd line to Rituxan be selling at ~$10M/year?? 3rd line? 4th?

micro